Synapse - Works

Results (4925)

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative genomic and transcriptomic characterization of Burkitt lymphoma

Meeting Abstract

Grande, B. M.; Gerhard, D. S.; Griner, N. B.; Casper, C.; Namirembe, C.; Omoding, A.; Orem, J.; Mbulaiteye, S. M.; Mullighan, C. G.; Sandlund, J. T.; more...
Blood (2017)

Fulltext@MSK | Save

Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies

Meeting Abstract

Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
Blood (2017)

Fulltext@MSK | Save

Personalized prognostic predictions for patients with myeloproliferative neoplasms through integration of comprehensive genomic and clinical information

Meeting Abstract

Grinfeld, J.; Nangalia, J.; Baxter, E. J.; Godfrey, A. L.; Guglielmelli, P.; Cantrill, R.; Wedge, D.; Angelopoulos, N.; Gundem, G.; Massie, C.; more...
Blood (2017)

Fulltext@MSK | Save

Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (CML) in the BFORE trial: 18 month follow-up

Meeting Abstract

Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; le Coutre, P. D.; Gutierrez, V. G.; more...
Blood (2017)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation for multiple myeloma benefits patients with persistent disease and results in a high rate of residual disease clearance

Meeting Abstract

Getta, B.; Roshal, M.; Koehne, G.
Blood (2017)

Fulltext@MSK | Save

Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1

Meeting Abstract

Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
Blood (2017)

Fulltext@MSK | Save

Results from an ongoing phase 1 study indicate ACDT-301 (camidanlumab tesirine) is well-tolerated in patients with relapsed or refractory CD25-positive acute leukemia

Meeting Abstract

Goldberg, A. D.; Tallman, M. S.; Solh, M. M.; Ungar, D.; Rizzieri, D. A.; Walter, R. B.; Spira, A. I.; Chung, K. Y.; Stock, W.; He, S.; more...
Blood (2017)

Fulltext@MSK | Save

Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma

Meeting Abstract

Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
Blood (2017)

Fulltext@MSK | Save

Lineage deconvolution using chromatin accessibility and DNA methylation shows a spectrum of lineage characteristics and differentiation states across acute leukemias

Meeting Abstract

Glass, J. L.; Palia, A. J.; Garrett-Bakelman, F. E.; Koche, R.; Levine, R. L.; Tallman, M. S.; Dillon, R. J.; Grimwade, D.; Ferrando, A. A.; Valk, P. J. M.; more...
Blood (2017)

Fulltext@MSK | Save

Natural history of hypogammaglobulinemia in patients with follicular lymphoma and the impact of anti-CD20-based therapy

Meeting Abstract

Fischer, T.; Ni, A.; Soumerai, J. D.; Alperovich, A.; Batlevi, C. L.; Younes, A.; Zelenetz, A. D.
Blood (2017)

Fulltext@MSK | Save